Order Article Reprints

Senguttuvan RN, Cho H, Wu X, Frankel PH, Ruel N, Yost SE, Kebria M, Han E, Song M, de Leon M, et al. Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345. Antioxidants. 2025; 14(12):1479. https://doi.org/10.3390/antiox14121479

Senguttuvan, Rosemary N., Hyejin Cho, Xiwei Wu, Paul H. Frankel, Nora Ruel, Susan E. Yost, Mehdi Kebria, Ernest Han, Mihae Song, Maria de Leon, and et al. 2025. "Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345" Antioxidants 14, no. 12: 1479. https://doi.org/10.3390/antiox14121479

Senguttuvan, R. N., Cho, H., Wu, X., Frankel, P. H., Ruel, N., Yost, S. E., Kebria, M., Han, E., Song, M., de Leon, M., Invernizzi, M., Eng, M., Tinsley, R., Salehian, B., Li, A., Schmolze, D., Chang, S., Arias-Stella, J., & Dellinger, T. H. (2025). Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345. Antioxidants, 14(12), 1479. https://doi.org/10.3390/antiox14121479